Carvinile 3.125
MRP: 480
Packaging: 10x10
Pack Type: tablet
Composition:
Carvedilol 3.125mg
Indication:
ESSENTIAL HYPERTENSION, POST INFARCTION PATIENT, HYPERTHYROIDISM, ANGINA PECTORIS, PROPHYLAXIS OF MIGRAINE
Description:
Carvedilol 3.125mg is a non-selective beta-blocker with alpha-1 blocking properties used to manage high blood pressure, heart failure, and to improve survival after a heart attack. By relaxing blood vessels and slowing heart rate, Carvedilol helps the heart pump more efficiently and reduces strain on the cardiovascular system.
This low dose (3.125mg) is commonly used as a starting dose in heart failure therapy, allowing for gradual titration to minimize risk of side effects such as hypotension or dizziness.
Tags:
- Low-dose beta-blocker for gentle titration
- Improves heart function in chronic heart failure
- Reduces risk of hospitalization
- Controls high blood pressure effectively
- Enhances survival post-myocardial infarction
- Well-tolerated when started at low doses
Usage Information
Dosage
Heart Failure (Adults): Start with 3.125 mg twice daily. Dose may be gradually increased every 2 weeks to a maximum of 25–50 mg/day depending on body weight and clinical response. Hypertension (Adults): Initial dose: 6.25 mg twice daily; lower starting doses (like 3.125 mg) may be used in sensitive individuals.
Side Effects
Dizziness or fatigue Slow heartbeat (bradycardia) Low blood pressure (hypotension) Weight gain or fluid retention Shortness of breath Cold hands/feet Rare: liver dysfunction, allergic reactions
Contraindications
Asthma or other bronchospastic conditions Severe liver impairment Second- or third-degree AV block (without pacemaker) Cardiogenic shock Sick sinus syndrome (without pacemaker) Known hypersensitivity to Carvedilol